BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The Framework Agreement includes the following range of products - Cervical Ripening Device Balloon, Postpartum Haemorrhage Device Balloon, PVC Ring Pessaries and Assisted Delivery Foetal Head Disimpaction Balloon. Precise quantities are unknown.
It is anticipated that initial expenditure will be in the region of £3m to £3.6m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
The estimated value over the total Framework Agreement term (including any extension options) will be in the region of £12m to £14.4m.
However these are approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Bray Group Ltd | 01396401 | ~£14,400,000 estimated from lot values | - |
| Origio Ltd | 03221787 | ~£14,400,000 estimated from lot values | - |
| Toffeln Ltd | 07564620 | ~£14,400,000 estimated from lot values | - |
| Trion Pharma Limited | 09293856 | ~£14,400,000 estimated from lot values | - |
Government spending data: These suppliers have received £12,119,737 in 418 payments (over £25k) from Department of Health and Social Care, NHS Supply Chain (DHSC-funded), Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust, UKRI (2019-03-13 to 2026-02-06).